Now in its 17th year, SCOPE returns February 2–5, 2026, to Rosen Shingle Creek in Orlando, Florida, bringing together the full clinical research ecosystem for four high-impact days of discussion, strategy, and networking.

SCOPE 2025 convened 4,500+ attendees, 630 speakers, and 300 exhibitors, with 60% in key decision-making roles, cementing its position as the premier event for clinical trial innovation.

Their 2026 program expands coverage of in-demand topics like Development Planning, Protocol Optimization, Patient-Centric Trial Design, Site Engagement & Recruitment, Generative AI, Small Biopharma Strategies, RBQM, Supply and ClinTech Investment—all focused on advancing solutions in trial planning, operations, innovation, and investment.

SCOPE Summit welcomes senior executives from pharma, biotech, CROs, sites, technology, investment, and patient advocacy organizations, representing over 1,200 companies across 30 countries.

View the event here.